163 related articles for article (PubMed ID: 25345911)
21. The radiological patterns of interstitial change at an early phase: over a 4-year follow-up.
Tsushima K; Sone S; Yoshikawa S; Yokoyama T; Suzuki T; Kubo K
Respir Med; 2010 Nov; 104(11):1712-21. PubMed ID: 20538446
[TBL] [Abstract][Full Text] [Related]
22. [Three cases of indium lung].
Taguchi O; Chonan T
Nihon Kokyuki Gakkai Zasshi; 2006 Jul; 44(7):532-6. PubMed ID: 16886812
[TBL] [Abstract][Full Text] [Related]
23. Relationship between indium exposure and oxidative damage in workers in indium tin oxide production plants.
Liu HH; Chen CY; Chen GI; Lee LH; Chen HL
Int Arch Occup Environ Health; 2012 May; 85(4):447-53. PubMed ID: 21833746
[TBL] [Abstract][Full Text] [Related]
24. Interstitial lung disease in coppersmiths in high serum copper levels.
Dagli CE; Tanrikulu AC; Koksal N; Abakay A; Gelen ME; Demirpolat G; Yuksel M; Atilla N; Tolun FI
Biol Trace Elem Res; 2010 Oct; 137(1):63-8. PubMed ID: 19921115
[TBL] [Abstract][Full Text] [Related]
25. [Pulmonary disorders in indium-processing workers].
Nogami H; Shimoda T; Shoji S; Nishima S
Nihon Kokyuki Gakkai Zasshi; 2008 Jan; 46(1):60-4. PubMed ID: 18260313
[TBL] [Abstract][Full Text] [Related]
26. An advanced case of indium lung disease with progressive emphysema.
Nakano M; Tanaka A; Hirata M; Kumazoe H; Wakamatsu K; Kamada D; Omae K
J Occup Health; 2016 Sep; 58(5):477-481. PubMed ID: 27488043
[TBL] [Abstract][Full Text] [Related]
27. [Changes of serum Krebs von den Lungen-6 levels in interstitial lung disease associated with dermatomyositis and secondary Sjögren's syndrome: a case report].
Yu JF; Jin YB; He J; An Y; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):910-914. PubMed ID: 29045979
[TBL] [Abstract][Full Text] [Related]
28. Krebs von den Lungen-6 and surfactant protein-A in interstitial pneumonia with autoimmune features.
Xue M; Cai C; Zeng Y; Xu Y; Chen H; Hu H; Zhou L; Sun B
Medicine (Baltimore); 2021 Jan; 100(4):e24260. PubMed ID: 33530214
[TBL] [Abstract][Full Text] [Related]
29. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.
Oguz EO; Kucuksahin O; Turgay M; Yildizgoren MT; Ates A; Demir N; Kumbasar OO; Kinikli G; Duzgun N
Clin Rheumatol; 2016 Mar; 35(3):663-6. PubMed ID: 26758437
[TBL] [Abstract][Full Text] [Related]
30. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
[TBL] [Abstract][Full Text] [Related]
31. Circulating markers of interstitial lung disease and subsequent risk of lung cancer.
Shiels MS; Chaturvedi AK; Katki HA; Gochuico BR; Caporaso NE; Engels EA
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2262-72. PubMed ID: 21828236
[TBL] [Abstract][Full Text] [Related]
32. Patterns of interstitial lung disease during everolimus treatment in patients with metastatic renal cell carcinoma.
Mizuno R; Asano K; Mikami S; Nagata H; Kaneko G; Oya M
Jpn J Clin Oncol; 2012 May; 42(5):442-6. PubMed ID: 22438405
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of diffuse parenchymal lung diseases among Turkish tinners.
Dikensoy O; Kervancioglu R; Ege I; Uysal N; Elbek O; Ozkur A
J Occup Health; 2008; 50(2):208-11. PubMed ID: 18403874
[TBL] [Abstract][Full Text] [Related]
34. Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control study.
Nakamura K; Kato M; Shukuya T; Mori K; Sekimoto Y; Ihara H; Kanemaru R; Ko R; Shibayama R; Tajima K; Koyama R; Shimada N; Nagashima O; Takahashi F; Sasaki S; Takahashi K
BMC Cancer; 2017 May; 17(1):302. PubMed ID: 28464801
[TBL] [Abstract][Full Text] [Related]
35. Idiopathic pleuroparenchymal fibroelastosis is characterized by an elevated serum level of surfactant protein-D, but Not Krebs von den Lungen-6.
Sato S; Hanibuchi M; Fukuya A; Yabuki Y; Bando H; Yoshijima T; Goto H; Ogawa H; Nishioka Y
Lung; 2014 Oct; 192(5):711-7. PubMed ID: 24880792
[TBL] [Abstract][Full Text] [Related]
36. Elevated Serum Krebs von den Lungen-6 in Early Disease Predicts Subsequent Deterioration of Pulmonary Function in Patients with Systemic Sclerosis and Interstitial Lung Disease.
Kuwana M; Shirai Y; Takeuchi T
J Rheumatol; 2016 Oct; 43(10):1825-1831. PubMed ID: 27481907
[TBL] [Abstract][Full Text] [Related]
37. Usefulness and performance evaluation of serum KL-6 and SP-A assays in healthy individuals and patients with interstitial lung disease.
Cho EJ; Hong J; Hyun J; Lee W; Kim HS; Chun S; Min WK
Clin Biochem; 2023 Aug; 118():110609. PubMed ID: 37414329
[TBL] [Abstract][Full Text] [Related]
38. Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study.
Chen F; Lu X; Shu X; Peng Q; Tian X; Wang G
Intern Med J; 2015 Jun; 45(6):641-7. PubMed ID: 25827843
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the clinical performance of the HISCL-5000 analyzer in the detection of Krebs von den Lungen-6 antigen and its diagnostic value in interstitial lung disease.
Wang J; Huang Z; Xue M; Huang H; Zheng X; Zhong N; Sun B
J Clin Lab Anal; 2020 Feb; 34(2):e23070. PubMed ID: 31691368
[TBL] [Abstract][Full Text] [Related]
40. Early detection of colon cancer by increased serum level of Krebs von den Lungen-6 in a patient with dermatomyositis-associated interstitial pneumonia.
Fukuhara N; Tanino Y; Sato S; Fukuhara A; Uematsu M; Nikaido T; Misa K; Sato Y; Saito J; Wang X; Munakata M
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):265-70. PubMed ID: 26422573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
